BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021
Jun 3, 2022
Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in… Read More
© 2024 CSRXP- All Rights Reserved
Updates
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA TARGETS MOST PROFITABLE DRUGS FOR NEW FORMULATIONS TO BLOCK COMPETITION
May 25, 2022
Brand Name Drug Companies Four Times as Likely to Reformulate Blockbuster… Read More
ICYMI: ANALYSIS REVEALS IMPACT OF BIG PHARMA’S ANTI-COMPETITIVE PRACTICES AROUND INHALERS
May 18, 2022
Brand Name Drug Companies Prevent Competition from More Affordable… Read More
BIG PHARMA WATCH: NEW ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING ON TOP DRUGS
May 13, 2022
Part D Spending on 10 Most Popular Medications Over Five Years Averages Five… Read More
BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, ABBVIE, ASTRAZENECA AND PFIZER
May 6, 2022
Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After… Read More
DOSE OF REALITY: SENATE COMMERCE HEARING OPPORTUNITY FOR LAWMAKERS TO HOLD BIG PHARMA ACCOUNTABLE
May 3, 2022
Lawmakers Should Focus Attention on Brand Name Drug Companies’ Egregious… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, GLAXOSMITHKLINE, AMGEN, ROCHE
Apr 29, 2022
Big Pharma Giants Repeatedly Hike Prices and Continue to Beat Wall Street… Read More
CSRXP AD CAMPAIGN: AMERICAN PEOPLE HAVE WAITED LONG ENOUGH; CONGRESS MUST HOLD BIG PHARMA ACCOUNTABLE
Apr 28, 2022
Seven-Figure Campaign Calls on Lawmakers to Reject Big Pharma’s Blame Game… Read More
ICYMI: NEW SURVEY FINDS VOTERS CONTINUE TO BLAME BIG PHARMA FOR OUT-OF-CONTROL DRUG PRICES, SUPPORT CONGRESSIONAL ACTION
Apr 27, 2022
Patients for Affordable Drugs Now Poll Finds Vast Majority of Voters Reject… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 20, 2022
J&J Beats Q1 Earnings Expectations, Announces Dividend Increase After… Read More
ICYMI: THE NEW YORK TIMES EDITORIAL BOARD ENDORSES SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Apr 18, 2022
Highlights How Administration and Lawmakers Can Fix Loopholes Exploited by… Read More
CSRXP: FINALIZED CMS COVERAGE DECISION FOR ADUHELM PROTECTS SENIORS AND TAXPAYERS FROM BIG PHARMA PRICE-GOUGING
Apr 8, 2022
Decision Appropriately Balances Access to Treatment with the Need for More… Read More